Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Disease × Ipilimumab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 100 Carcinoma, Non-Small-Cell Lung 26 Neoplasms 23 Neoplasm Metastasis 16 Carcinoma, Renal Cell 16 Prostatic Neoplasms 15 Uveal Melanoma 14 Lung Neoplasms 12 Pancreatic Neoplasms 11 Diabetes Mellitus, Insulin-Dependent, 12 11 Small Cell Lung Carcinoma 10 Colorectal Neoplasms 10 Carcinoma, Hepatocellular 9 Uterine Cervical Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 8 Breast Neoplasms 8 Stomach Neoplasms 6 Sarcoma 6 Mesothelioma 6 Kidney Neoplasms 6 Head and Neck Neoplasms 6 Carcinoma, Transitional Cell 6 Recurrence 5 Ovarian Neoplasms 5 Lymphoma, Non-Hodgkin 5 Leukemia, Myeloid, Acute 5 Hodgkin Disease 5 Endometrial Neoplasms 5 Brain Neoplasms 5 Urinary Bladder Neoplasms 4

Interventions

Dexamethasone 5 Magnetic Resonance Spectroscopy 4 Cyclophosphamide 4 Blood Specimen Collection 4 Surveys and Questionnaires 3 Prednisone 3 Melphalan 3 Lenalidomide 3 Biopsy, Fine-Needle 3 fluciclovine F-18 2 carfilzomib 2 Positron-Emission Tomography 2 Mammography 2 Injections 2 Immunohistochemistry 2 Gemcitabine 2 Cytarabine 2 weifuchun 1 vistusertib 1 venetoclax 1 ricolinostat 1 pomalidomide 1 phosphoribosylformylglycinamidine synthetase 1 pembrolizumab 1 ofatumumab 1 obinutuzumab 1 irinotecan sucrosofate 1 ibrutinib 1 gossypol acetic acid 1 glycidol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04855929 2024-11-08

ANV419-001

Anaveon AG

Phase 1 Completed

Disease, Lung Neoplasms, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡